{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:04:48Z","timestamp":1790643888554,"version":"4.1.0"},"reference-count":60,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Most patients with bronchiectasis have a predominantly neutrophilic inflammatory profile, although other cells such as lymphocytes (as controllers of bronchial inflammation) and eosinophils also play a significant pathophysiological role. Easy-to-interpret blood biomarkers with a discriminative capacity for severity or prognosis are needed. The objective of this study was to assess whether the peripheral neutrophil-to-lymphocyte ratio (NLR) is associated with different outcomes of severity in bronchiectasis. A total of 1369 patients with bronchiectasis from the Spanish Registry of Bronchiectasis were included. To compare groups, the sample was divided into increasing quartiles of NLR ratio. Correlations between quantitative variables were established using Pearson\u2019s P test. A simple linear regression (with the value of exacerbations as a quantitative variable) was used to determine the independent relationship between the number and severity of exacerbations and the NLR ratio. The area under the curve (AUC)-ROC was used to determine the predictive capacity of the NLR for severe bronchiectasis, according to the different multidimensional scores. Mean age: 69 (15) years (66.3% of women). The mean NLR was 2.92 (2.03). A higher NLR was associated with more severe bronchiectasis (with an especially significant discriminative power for severe forms) according to the commonly used scores (FACED, E-FACED and BSI), as well as with poorer quality of life (SGRQ), more comorbidities (Charlson index), infection by pathogenic microorganisms, and greater application of treatment. Furthermore, the NLR correlated better with severity scores than other parameters of systemic inflammation. Finally, it was an independent predictor of the incident number and severity of exacerbations. In conclusion, the NLR is an inexpensive and easy-to-measure marker of systemic inflammation for determining severity and predicting exacerbations (especially the most severe) in patients with bronchiectasis.<\/jats:p>","DOI":"10.3390\/biom12101399","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:07:43Z","timestamp":1665187663000},"page":"1399","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-1891","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Martinez-Garc\u00eda","sequence":"first","affiliation":[{"name":"Servicio de Neumolog\u00eda e Instituto de Investigaci\u00f3n La Fe (IISLAFE), Hospital Universitario y Polit\u00e9cnico La Fe, 46026 Valencia, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-7400","authenticated-orcid":false,"given":"Casilda","family":"Olveira","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), Hospital Regional Universitario de M\u00e1laga, Universidad de M\u00e1laga, 29010 M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7094-0848","authenticated-orcid":false,"given":"Rosa","family":"Gir\u00f3n","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Instituto de Investigaci\u00f3n Sanitaria, Hospital Universitario de la Princesa, 28006 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0463-5946","authenticated-orcid":false,"given":"Marta","family":"Garc\u00eda-Clemente","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Instituto de investigaci\u00f3n biosanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"M\u00e1iz-Carro","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Hospital Ram\u00f3n y Cajal, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, 28220 Madrid, Spain"},{"name":"Servicio de Neumolog\u00eda, Hospital Cl\u00ednic, IDIBAPS, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3759-5322","authenticated-orcid":false,"given":"Rafael","family":"Golpe","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Hospital Lucus Augusti, 27003 Lugo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6300-9836","authenticated-orcid":false,"given":"Ra\u00fal","family":"M\u00e9ndez","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda e Instituto de Investigaci\u00f3n La Fe (IISLAFE), Hospital Universitario y Polit\u00e9cnico La Fe, 46026 Valencia, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-2484","authenticated-orcid":false,"given":"Juan Luis","family":"Rodr\u00edguez Hermosa","sequence":"additional","affiliation":[{"name":"Pulmonary Department, Research Institute of Hospital Cl\u00ednico San Carlos (IdISSC), Faculty of Medicine, University Complutense of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Barreiro","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Hospital del Mar-IMIM, UPF, CIBERES, 08003 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Prados","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Hospital La Paz, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Rodr\u00edguez L\u00f3pez","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Hospital San Agust\u00edn, Avil\u00e9s, 33410 Asturias, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0753-1771","authenticated-orcid":false,"given":"David","family":"de la Rosa","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Hospital Santa Creu i Sant Pau, 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: Endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.rmed.2007.06.028","article-title":"Dissociation of lung function, dyspnea ratings and pulmonary extension in bronchiectasis","volume":"101","author":"Soler","year":"2007","journal-title":"Respir. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2017.04.009","article-title":"The heterogeneity of systemic inflammation in bronchiectasis","volume":"127","author":"Saleh","year":"2017","journal-title":"Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1513\/AnnalsATS.201510-678OC","article-title":"The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis A Cluster Analysis Approach","volume":"13","author":"Vendrell","year":"2016","journal-title":"Annu. Am. Thorac. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2100777","DOI":"10.1183\/13993003.00777-2021","article-title":"Heterogeneity of treatment response in bronchiectasis clinical trials","volume":"59","author":"Sibila","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev-pathol-012615-044344","article-title":"Bronchiectasis: Current Concepts in Pathogenesis, Immunology, and Microbiology","volume":"11","author":"Boyton","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1183\/09031936.00069007","article-title":"Mucosal inflammation in idiopathic bronchiectasis: Cellular and molecular mechanisms","volume":"31","author":"Fuschillo","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/thx.53.8.685","article-title":"Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis","volume":"53","author":"Gaga","year":"1998","journal-title":"Thorax"},{"key":"ref_9","first-page":"681","article-title":"Repeteability of Circulating Eosinophil Measures and Inhaled Corticosteroids Effect in Bronchiectasis. A Post Hoc Analysis of a Randomized Clinical Trial","volume":"56","author":"Posadas","year":"2020","journal-title":"Arch. Bronconeumol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterisation of Eosinophilic Bronchiectasis: A European Multicohort Study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","first-page":"671","article-title":"Bronchiectasis and eosinophils","volume":"57","year":"2021","journal-title":"Arch. Bronconeumol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2249.2006.03091.x","article-title":"Assessing immune function in adult bronchiectasis","volume":"144","author":"King","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.arbres.2019.12.017","article-title":"C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)","volume":"57","author":"Posadas","year":"2021","journal-title":"Arch. Bronconeumol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1579-2129(08)60003-8","article-title":"The association between bronchiectasis, systemic inflammation, and tumor necrosis factor alpha","volume":"44","author":"Yago","year":"2008","journal-title":"Arch. Bronconeumol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jand.2012.08.013","article-title":"Fat-free mass depletion and inflammation in patients with bronchiectasis","volume":"112","author":"Olveira","year":"2012","journal-title":"J. Acad. Nutr. Diet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clnu.2012.06.002","article-title":"Cellular and plasma oxidative stress biomarkers are raised in adults with bronchiectasis","volume":"32","author":"Olveira","year":"2013","journal-title":"Clin. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wang, X., Villa, C., Dobarganes, Y., Olveira, C., Gir\u00f3n, R., Garc\u00eda-Clemente, M., Ma\u00edz, L., Sibila, O., Golpe, R., and Men\u00e9ndez, R. (2021). Differences in Nutritional Status and Inflammatory Biomarkers between Female and Male Patients with Bronchiectasis: A Large-Cohort Study. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080905"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wang, X., Olveira, C., Gir\u00f3n, R., Garc\u00eda-Clemente, M., M\u00e1iz, L., Sibila, O., Golpe, R., Men\u00e9ndez, R., Rodr\u00edguez-L\u00f3pez, J., and Prados, C. (2022). Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051044"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wang, X., Villa, C., Dobarganes, Y., Olveira, C., Gir\u00f3n, R., Garc\u00eda-Clemente, M., M\u00e1iz, L., Sibila, O., Golpe, R., and Men\u00e9ndez, R. (2021). Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18168431"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.chest.2020.11.011","article-title":"A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile","volume":"159","author":"Perea","year":"2020","journal-title":"Chest"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1900303","DOI":"10.1183\/13993003.00303-2019","article-title":"A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation","volume":"53","author":"Shoemark","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.202002-0434LE","article-title":"Serum Desmosine Is Associated with Long-Term All-Cause and Cardiovascular Mortality in Bronchiectasis","volume":"202","author":"Huang","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.2147\/COPD.S178068","article-title":"Defining the role of neutrophil-to-lymphocyte ratio in COPD: A systematic literature review","volume":"13","author":"Dorca","year":"2018","journal-title":"Int. J. COPD"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"170113","DOI":"10.1183\/16000617.0113-2017","article-title":"Neutrophil to lymphocite ratio and clinical outcomes in COPD: Recent evidence and future perspectives","volume":"27","author":"Paliogiannis","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_27","first-page":"382","article-title":"Evaluation of the relationship of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of COPD","volume":"15","year":"2020","journal-title":"Clin. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/17476348.2020.1776613","article-title":"The predictive value of neutrophil-to-lymphocyte ratio for chronic obstructive pulmonary disease: A systematic review and meta-analysis","volume":"14","author":"Guo","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Alzoubi, O., and Khanfar, A. (2021). Association between neutrophil to lymphocyte ratio and mortality among community acquired pneumonia patients: A meta-analysis. Monaldi Arch. Chest Dis., 92.","DOI":"10.4081\/monaldi.2021.2050"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, C.E., and Price, E.T. (2013). The blood neutrophil to lymphocyte ratio correlates with clinical status in children with cystic fibrosis: A retrospective study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077420"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ruta, V.M., Man, A.M., Alexescu, T.G., Motoc, N.S., Tarmure, S., Ungur, R.A., Todea, D.A., Coste, S.C., Valean, D., and Pop, M.C. (2020). Neutrophil-To-Lymphocyte Ratio and Systemic Immune-Inflammation Index-Biomarkers in Interstitial Lung Disease. Medicina, 56.","DOI":"10.3390\/medicina56080381"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lu, Y., Jiang, J., and Ren, C. (2020). The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230979"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.21037\/tlcr-20-777","article-title":"Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancer","volume":"10","author":"Ishihara","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1076029619900549","DOI":"10.1177\/1076029619900549","article-title":"Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism","volume":"26","author":"Phan","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13849","DOI":"10.18632\/aging.103582","article-title":"High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: A multicenter retrospective study","volume":"30","author":"Lian","year":"2020","journal-title":"Aging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5114\/ceji.2017.72808","article-title":"Can mean platelet volumen and neutrophil-to-lymphocyte ratio be biomarkers of acute exacerbation of bronchiectasis in children?","volume":"42","author":"Nacaroglu","year":"2017","journal-title":"Clin. Immunol. Cent. Eur. J. Immunol."},{"key":"ref_37","first-page":"e9728","article-title":"Neutrophils to Lymphocyte Ratio as a Biomarker in Bronchiectasis Exacerbation: A Retrospective Study","volume":"12","author":"Georgakopoulou","year":"2020","journal-title":"Cureus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.arbr.2020.11.010","article-title":"RIBRON: The Spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients","volume":"57","author":"Villa","year":"2021","journal-title":"Arch. Bronconeumol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: The FACED score","volume":"43","author":"Vendrell","year":"2014","journal-title":"Eur. Resp. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: The E-FACED score","volume":"12","author":"Athanazio","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbr.2017.07.014","article-title":"Spanish guidelines on treatment of bronchiectasis in adults","volume":"54","author":"Olveira","year":"2018","journal-title":"Arch. Bronconeumol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the Frequent Exacerbator Phenotype in Bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_44","first-page":"81","article-title":"Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship with Disease Severity","volume":"55","author":"Athanazio","year":"2019","journal-title":"Arch. Bronconeumol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.arbr.2020.08.006","article-title":"Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease","volume":"56","year":"2020","journal-title":"Arch. Bronconeumol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/thoraxjnl-2018-212895","article-title":"Antimicrobial peptides, disease severity and exacerbations in bronchiectasis","volume":"74","author":"Sibila","year":"2019","journal-title":"Thorax"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2003157","DOI":"10.1183\/13993003.03157-2020","article-title":"Neutrophil dysfunction in bronchiectasis: An emerging role for immunometabolism","volume":"58","author":"Giam","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1164\/rccm.201712-2423OC","article-title":"Blood Neutrophils Are Reprogrammed in Bronchiectasis","volume":"198","author":"Bedi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"642503","DOI":"10.1155\/2015\/642503","article-title":"Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis","volume":"2015","author":"Dente","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2012.09.011","article-title":"Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis","volume":"55","author":"Chalmers","year":"2013","journal-title":"Mol. Immunol."},{"key":"ref_51","first-page":"702","article-title":"The neutrophil-to-lymphocyte ratio: A narrative review","volume":"10","author":"Faria","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41598-020-79431-7","article-title":"Neutrophil-to-lymphocyte ratio and mortality in the United States general population","volume":"11","author":"Song","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e2010350","DOI":"10.1001\/jamanetworkopen.2020.10350","article-title":"Association of Neutrophil to Lymphocyte Ratio with Pulmonary Function in a 30-Year Longitudinal Study of US Veterans","volume":"3","author":"Gao","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_54","first-page":"9874068","article-title":"Is there a correlation between new scoring systems and systemic inflammation in stable bronchiectasis?","volume":"2017","author":"Coban","year":"2017","journal-title":"Can. Resp. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1701953","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"51","author":"Shteinberg","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.arbr.2019.04.014","article-title":"Look at the wood and not at the tree: The Microbiome in Chronic Obstructive Lung Disease and Cystic Fibrosis","volume":"56","year":"2020","journal-title":"Arch. Bronconeumol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/QCO.0000000000000628","article-title":"Managing and preventing exacerbation of bronchiectasis","volume":"33","author":"Chalmers","year":"2020","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.arbres.2019.12.010","article-title":"The Roles of Bacteria and Viruses in Bronchiectasis Exacerbation: A Prospective Study","volume":"56","author":"Chen","year":"2020","journal-title":"Arch. Bronconeumol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/COPD.S132961","article-title":"Bronchiectasis in COPD patients: More than a comorbidity?","volume":"12","author":"Miravitlles","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ryu, W.K., Moon, Y., Park, M.H., Lim, J.H., Kim, Y.S., Lee, K.H., Kwak, S.M., Kim, C., and Nam, H.S. (2021). A Preliminary Study on the Prognostic Impact of Neutrophil to Lymphocyte Ratio of the Bronchoalveolar Lavage Fluid in Patients with Lung Cancer. Diagnostics, 11.","DOI":"10.3390\/diagnostics11122201"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/10\/1399\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:44:26Z","timestamp":1760143466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/10\/1399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":60,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biom12101399"],"URL":"https:\/\/doi.org\/10.3390\/biom12101399","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]}}}